{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T15:10:47Z","timestamp":1771341047565,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04608-5","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T12:14:37Z","timestamp":1769256877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Barriers to immediate corticosteroid treatment in suspected giant cell arteritis with visual symptoms: insights from a tertiary eye care unit"],"prefix":"10.1186","volume":"26","author":[{"given":"Won Young","family":"Moon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Hornby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lloyd","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria Anne","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirish","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"4608_CR1","doi-asserted-by":"crossref","unstructured":"Prior JA, Ranjbar H, Belcher J, Mackie SL, Helliwell T, Liddle J et al. Diagnostic delay for giant cell arteritis - a systematic review and meta-analysis. BMC Med. 2017;15.","DOI":"10.1186\/s12916-017-0871-z"},{"key":"4608_CR2","doi-asserted-by":"publisher","unstructured":"Mackie SL, Dejaco C, Appenzeller S, Camellino D, Duftner C, Gonzalez-Chiappe S et al. March. British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis. Rheumatology. 2020;59(3):e1-e23. https:\/\/doi.org\/10.1093\/rheumatology\/kez672. Accessed 15 April 2025.","DOI":"10.1093\/rheumatology\/kez672"},{"key":"4608_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10067-010-1616-y","volume":"30","author":"AN Ezeonyeji","year":"2011","unstructured":"Ezeonyeji AN, Borg FA, Dasgupta B. Delays in recognition and management of giant cell arteritis: results from a retrospective audit. Clin Rheumatol. 2011;30:259\u201362. https:\/\/doi.org\/10.1007\/s10067-010-1616-y.","journal-title":"Clin Rheumatol"},{"key":"4608_CR4","unstructured":"Kay L, Lanyon P, MacGregor A. February. Rheumatology GIRFT programme national specialty report. Getting It Right First Time. 2021;125\u2013125. Available from https:\/\/gettingitrightfirsttime.co.uk\/wp-content\/uploads\/2021\/09\/Rheumatology-Jul21h-NEW.pdf. Accessed 15 April 2025."},{"key":"4608_CR5","doi-asserted-by":"publisher","unstructured":"Vodopivec I, Rizzo JF. Ophthalmic manifestations of giant cell arteritis. Rheumatology. 2018;57: ii63\u2013ii72. https:\/\/doi.org\/10.1093\/rheumatology\/kex428. Accessed 15 April 2025.","DOI":"10.1093\/rheumatology\/kex428"},{"issue":"4","key":"4608_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2478\/s13380-011-0034-1","volume":"2","author":"A Fakin","year":"2011","unstructured":"Fakin A, Kerin V, Hawlina M. Visual fields in giant cell arteritis (Horton\u2019s disease). Transl Neurosci. 2011;2(4):325\u201330. https:\/\/doi.org\/10.2478\/s13380-011-0034-1. Accessed 15 April 2025.","journal-title":"Transl Neurosci"},{"issue":"1","key":"4608_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/WNO.0000000000000843","volume":"40","author":"GL Jensen","year":"2020","unstructured":"Jensen GL, Al Othman B, Kini A, Prospero Ponce CM, Lee AG. Internuclear ophthalmoplegia as the presenting sign of giant cell arteritis. J Neuroophthalmol. 2020;40(1):92\u20134. https:\/\/doi.org\/10.1097\/WNO.0000000000000843.","journal-title":"J Neuroophthalmol"},{"key":"4608_CR8","doi-asserted-by":"publisher","unstructured":"Bilton EJ, Coath F, Patil A, Jones C, Eoin O\u2019Sullivan, Hingorani M et al. The first giant cell arteritis hospital quality standards (GHOST). Eye. 2023. Available from: https:\/\/doi.org\/10.1038\/s41433-023-02604-x. Accessed 15 April 2025.","DOI":"10.1038\/s41433-023-02604-x"},{"issue":"2","key":"4608_CR9","first-page":"103","volume":"33","author":"P Patil","year":"2015","unstructured":"Patil P, Williams M, Maw WW, Achilleos K, Elsideeg S, Dejaco C, et al. Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study. Clin Exp Rheumatol. 2015;33(2):103\u20136.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"4608_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/rheumatology\/kev289","volume":"55","author":"AP Diamantopoulos","year":"2016","unstructured":"Diamantopoulos AP, Haugeberg G, Lindland A, Myklebust G. The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis? Rheumatology (Oxford). 2016;55(1):66\u201370.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"4608_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/03009742.2022.2051279","volume":"52","author":"J Pinnell","year":"2023","unstructured":"Pinnell J, Tiivas C, Mehta P, Dubey S. Corticosteroids reduce vascular ultrasound sensitivity in fast- track pathways (FTP): results from Coventry Multi-Disciplinary FTP for cranial giant cell arteritis. Scand J Rheumatol. 2023;52(3):283\u201392. https:\/\/doi.org\/10.1080\/03009742.2022.2051279.","journal-title":"Scand J Rheumatol"},{"key":"4608_CR12","doi-asserted-by":"crossref","unstructured":"Hellmich B, Agueda A, Monti S, Buttgereit F, De Boysson H, Brouwer E et al. 2018 update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020;79.","DOI":"10.1136\/annrheumdis-2019-215672"},{"issue":"4","key":"4608_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1037\/a0025704","volume":"15","author":"H Gehlbach","year":"2011","unstructured":"Gehlbach H, Brinkworth ME. Measure twice, cut down error: a process for enhancing the validity of survey scales. Rev Gen Psychol. 2011;15(4):380\u20137. https:\/\/doi.org\/10.1037\/a0025704.","journal-title":"Rev Gen Psychol"},{"key":"4608_CR14","doi-asserted-by":"publisher","unstructured":"McMenamin L, Blencowe N, Roland D. Are educational or quality improvement interventions delivered at the induction or orientation of junior Doctors effective? J Hosp Adm. 2014;3(5). https:\/\/doi.org\/10.5430\/jha.v3n5p14. Accessed 15 April 2025.","DOI":"10.5430\/jha.v3n5p14"},{"issue":"4","key":"4608_CR15","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/rheumatology\/keae459","volume":"64","author":"J Hampus Henningson, Bj\u00f6rn Hammar, Al","year":"2025","unstructured":"Hampus Henningson, Bj\u00f6rn Hammar, Aladdin J, Mohammad. The use of intravenous Methylprednisolone in giant cell arteritis: a population-based study. Rheumatology. 2025;64(4):2083\u201390. https:\/\/doi.org\/10.1093\/rheumatology\/keae459.","journal-title":"Rheumatology"},{"issue":"1","key":"4608_CR16","doi-asserted-by":"publisher","first-page":"105641","DOI":"10.1016\/j.jbspin.2023.105641","volume":"91","author":"R For\u00e9","year":"2024","unstructured":"For\u00e9 R, Liozon E, Dumonteil S, Sen\u00e9 T, H\u00e9ron E, Lacombe V, et al. And French study group for large-vessel arteritis (GEFA); Gondran G. BOB-ACG study: pulse Methylprednisolone to prevent bilateral ophthalmologic damage in giant cell arteritis. a multicentre retrospective study with propensity score analysis. Joint Bone Spine. 2024;91(1):105641. https:\/\/doi.org\/10.1016\/j.jbspin.2023.105641.","journal-title":"Joint Bone Spine"},{"key":"4608_CR17","unstructured":"Stroke. and Transient ischaemic attack in over 16s: diagnosis and initial management. NICE guideline NG128; May 2019."},{"key":"4608_CR18","doi-asserted-by":"publisher","unstructured":"Maz M, Chung SA, Abril A, Langford CA, Gorelik M, Guyatt G et al. American college of rheumatology\/vasculitis foundation guideline for the management of giant cell arteritis and takayasu arteritis. Arthritis and Rheumatology. 2021;73(8). https:\/\/doi.org\/10.1002\/art.41774. Accessed 15 April 2025.","DOI":"10.1002\/art.41774"},{"key":"4608_CR19","doi-asserted-by":"publisher","unstructured":"Qureshi A, Halilu F, Serafi SW, Hauptman H, Flack T. Evidence-based role of aspirin in giant cell arteritis: a literature review. J Community Hosp Intern Med Perspect. 2022;12(5). https:\/\/doi.org\/10.55729\/2000-9666.1072.","DOI":"10.55729\/2000-9666.1072"},{"key":"4608_CR20","unstructured":"The Royal College of Ophthalmologists. The way forward emergency eye care report. 2017. https:\/\/www.rcophth.ac.uk\/wp-content\/uploads\/2017\/01\/RCOphth-The-Way-Forward-Emergency-Eye-Care-300117.pdf. Accessed 15 April 2025."},{"key":"4608_CR21","unstructured":"Lord Carter of Coles. Operational productivity and performance in English NHS acute hospitals: unwarranted variations. department of health. 2016. https:\/\/assets.publishing.service.gov.uk\/media\/5a80bdfae5274a2e87dbb8f5\/Operational_productivity_A.pdf. Accessed 15 April 2025."}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04608-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04608-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04608-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:21:25Z","timestamp":1771338085000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-025-04608-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4608"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04608-5","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Helsinki Declaration. Ethics approval was not required as per the Health Research Authority (HRA) tool in the UK. The study was approved by the governance committee in Oxford University Hospitals ophthalmology department as quality improvement project in the department (ref 8073). We provided the information about our project to all staff in EEC and participation in the online questionnaire was entirely voluntary. The questionnaire was designed to be anonymous, and no participant personal details were collected. Only the participants who consented to anonymised survey participated in this study. Implied consent was applicable in this study as per University of Oxford Research Ethics guideline:\n                      \n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}